Znn3bq.jpeg
±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 416  |  »Ø¸´: 3
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

yinlingling7839

ľ³æ (СÓÐÃûÆø)


[½»Á÷] Çë¸ßÊÖ·­ÒëÒ»¶Î»°

·ÇרÀûÒ©(non¡ªpatent drug)ÊÇÖ¸¡°Ò»¸öÒ©Æ·²»¾ßÓÐרÀûȨ£»»òרÀûȨ ¸÷ÖÖÔ­ ÖÕÖ¹£º»òרÀûȨÈ˶ÀÕ¼Éú²ú¡¢ÏúÊÛ¸ÃÒ©Æ·µÄȨÀûÏûʧ£»»òÉú²ú¸ÃÒ©Æ·µÄ¼¼Êõ½øÈ빫ÓÐÁìÓò£¬ ³ýרÀûȨÈËÍâµÄÆóÒµ¿ÉÒÔ²»ÊÜÈκÎÔ¼Êø¶ø×ÔÓÉÉú²ú¸ÃÒ©Æ·¡±¡£Ä¿Ç°£¬È«Çò·ÇרÀûÒ©Êг¡¼ÛֵԼΪ400ÒÚÃÀÔª×óÓÒ£¬²¢ÒÔÿÄê10%¡«15%µÄËÙ¶ÈÔö³¤£¬¸ßÓÚÈ«ÇòÖÆÒ©ÒµÕûÌå·¢Õ¹ËÙ¶È£¬·ÇרÀûÒ©¹«Ë¾·¢Õ¹ÊÆÍ·Ç¿¾¢

» ²ÂÄãϲ»¶

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
yinlingling7839(½ð±Ò+30, ·­ÒëEPI+1): 2011-03-21 08:28:53
²Î¿¼Ò»Ï°ɣ¬±Ï¾¹²»ÊÇÏàͬרҵ¡£¡£¡£
4Â¥2011-03-20 23:43:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 4 ¸ö»Ø´ð
·ÇרÀûÒ©(non¡ªpatent drug)ÊÇÖ¸¡°Ò»¸öÒ©Æ·²»¾ßÓÐרÀûȨ£»»òרÀûȨÒò¸÷ÖÖÔ­ÒòÖÕÖ¹£º»òרÀûȨÈ˶ÀÕ¼Éú²ú¡¢ÏúÊÛ¸ÃÒ©Æ·µÄȨÀûÏûʧ£»»òÉú²ú¸ÃÒ©Æ·µÄ¼¼Êõ½øÈ빫ÓÐÁìÓò£¬ ³ýרÀûȨÈËÍâµÄÆóÒµ¿ÉÒÔ²»ÊÜÈκÎÔ¼Êø¶ø×ÔÓÉÉú²ú¸ÃÒ©Æ·¡±

non-patent drug refers to a drug is not patented; or the original patent is terminated by some reasons; or the patentee¡¯s exclusive production and the rights of selling the drug are disappeared; or the technology of producing the drug inverts into the public domain. Except the patentee, every enterprise can produce this drug freely without any constraints.
2Â¥2011-03-20 23:35:59
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ŀǰ£¬È«Çò·ÇרÀûÒ©Êг¡¼ÛֵԼΪ400ÒÚÃÀÔª×óÓÒ£¬²¢ÒÔÿÄê10%¡«15%µÄËÙ¶ÈÔö³¤£¬¸ßÓÚÈ«ÇòÖÆÒ©ÒµÕûÌå·¢Õ¹ËÙ¶È£¬·ÇרÀûÒ©¹«Ë¾·¢Õ¹ÊÆÍ·Ç¿¾¢

Currently, the global market value of non-patent drug is about 400 billion U.S dollars with an increasing rate of 10% to 15% each year. It is much higher than the rate of the overall development of the global pharmaceutical industry which leads to the companies which produce the non-patent drug have a vibrant and strong momentum for development.
3Â¥2011-03-20 23:42:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 275Çóµ÷¼Á +4 1624447980 2026-04-08 5/250 2026-04-08 15:29 by ŶŶ123
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +10 ŬÁ¦·Ü¶·112 2026-04-07 10/500 2026-04-08 15:01 by screening
[¿¼ÑÐ] Ò»Ö¾Ô¸2110£¬»¯Ñ§Ñ§Ë¶310·Ö£¬±¾¿ÆÖصãË«·ÇÇóµ÷¼Á +12 ŬÁ¦·Ü¶·112 2026-04-08 12/600 2026-04-08 14:28 by 418490947
[¿¼ÑÐ] 311Çóµ÷¼Á +4 surte 2026-04-08 8/400 2026-04-08 14:27 by 418490947
[¿¼ÑÐ] 302·ÖÇóµ÷¼Á +3 ·²ÓïÆíÔ¸ 2026-04-08 4/200 2026-04-08 14:24 by zhq0425
[¿¼ÑÐ] 280Çóµ÷¼Á +9 Àîrien 2026-04-04 9/450 2026-04-08 13:20 by lijunpoly
[ÂÛÎÄͶ¸å] Decision: Revise for Editor»¹»áËÍÉóÂð 100+3 CccccccccFD 2026-04-04 5/250 2026-04-07 10:58 by ±±¾©À³ÒðÈóÉ«
[¿¼ÑÐ] ÉúÎïѧµ÷¼Á ¿Éµ÷¼Áµ½ÉúÎïÓëÒ½Ò© +3 ÀîÕþÓ¨ 2026-04-06 3/150 2026-04-06 19:02 by macy2011
[¿¼ÑÐ] Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ²ÄÁϹ¤³Ì£¬³õÊÔ344Çóר˶µ÷¼Á +6 15933906766 2026-04-05 6/300 2026-04-06 13:21 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 0854Çóµ÷¼Á +4 assdll 2026-04-05 4/200 2026-04-06 12:29 by ÖзÉÔº¿Õ¹ÜѧԺÑ
[¿¼ÑÐ] Ò»Ö¾Ô¸211ÉúÎïѧ280·Ö Çóµ÷¼Á +5 Àîrien 2026-04-05 5/250 2026-04-06 10:30 by zhyzzh
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +6 Ò»ÑùYWY 2026-04-05 6/300 2026-04-05 20:30 by ÄϺ½~ÍòÀÏʦ
[¿¼ÑÐ] 323Çóµ÷¼Á +8 Àî¼ÑÀÖ1 2026-04-04 8/400 2026-04-04 22:26 by hemengdong
[¿¼ÑÐ] 342Çóµ÷¼Á +3 Liang7111 2026-04-04 5/250 2026-04-04 19:47 by dongzh2009
[¿¼ÑÐ] Çóµ÷¼Á +6 Ë·Ë·»° 2026-04-02 7/350 2026-04-04 19:16 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 266Çóµ÷¼Á +8 ѧԱ97LZgn 2026-04-03 8/400 2026-04-04 09:02 by 20021109
[¿¼ÑÐ] ¿¼Ñе÷¼Á +5 СsunÒªºÃÔË 2026-04-03 5/250 2026-04-03 21:43 by à£à£à£0119
[¿¼ÑÐ] ÉúÎïѧ˶341Çóµ÷¼Á +4 ÄãЦÆðÀ´ÏñÔÆ¶ä 2026-04-03 4/200 2026-04-03 10:32 by macy2011
[¿¼ÑÐ] 312Çóµ÷¼Á +4 ÉÞÔÂÉ« 2026-04-02 5/250 2026-04-03 08:21 by fangshan711
[¿¼ÑÐ] 348»·¾³¹¤³Ìµ÷¼Á +3 ÎâÑå׿24k 2026-04-01 3/150 2026-04-02 09:14 by nanaliuyun
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û